Now livetag icon
2026 State of Ecommerce: Own the AI Shopper Journey.Download Reportbanner icon
LianBio

August 2026

LianBio Market Share Analysis for August 2026

LianBio is a Chinese company focused on bringing paradigm-shifting medicines to patients through partnerships that provide access to the best science-driven therapeutic discoveries.
Year Founded2019
Employees51 - 200
Annual Revenue--
lianbio.com
LianBio
LianBio (including company regionals)
  • lianbio.com
    lianbio.com
See more website traffic and engagement information

Total visits to LianBio's top domains

Understand LianBio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in LianBio's top domains

Analyze LianBio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on LianBio's top domains

See how LianBio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


LianBio top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by LianBio

These are the website technologies, by industry, used by LianBio top domains

Advertising (2)

Google Adsense

Google Adsense

Content Management System (2)

WebFlow

WebFlow

Mobile (2)

Meta Viewport

Meta Viewport

Conversion & Analytics (1)

Cloudflare Insights

Cloudflare Insights

More Technologies

3

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from LianBio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLianBio sold assets to Grandpharma on Mar 1st '24.Grand Pharma acquired these rights from LianBio through a novation agreement executed in March 2024, assuming all obligations under the original licensing deal between LianBio and Tarsus.
NewsLianBio sells assets to Nimmunebio.US privately-held drug developer NImmune Biopharma has acquired development and commercialization rights for omilancor in Asia from Sino-American biotech LianBio.
NewsLianBio decreases headcount by 50.LianBio plans to sell remaining assets and lay off 50 employees initially, with further cuts to follow.

See all LianBio signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.